Dapagliflozin 5mg + Vildagliptin 50mg is a prescription oral medication used for the management of type 2 diabetes mellitus. This combination works through dual mechanisms: Dapagliflozin, an SGLT2 inhibitor, reduces glucose reabsorption in the kidneys and promotes urinary glucose excretion, while Vildagliptin, a DPP-4 inhibitor, enhances the body’s natural incretin hormones, increasing insulin secretion and reducing glucagon levels in response to meals. Together, they help achieve better glycemic control and maintain stable blood sugar levels. This formulation is particularly beneficial for patients who require complementary mechanisms to manage hyperglycemia, improve HbA1c levels, and support weight management. It is usually prescribed along with diet and exercise for optimal results.
